Takeda Pharmaceutical
92 hedge funds and large institutions have $910M invested in Takeda Pharmaceutical in 2018 Q4 according to their latest regulatory filings, with 83 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
6.8% more ownership
Funds ownership: 0% → 6.8% (+6.8%)
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
Holders
92
Holding in Top 10
1
Calls
$7.49M
Puts
$4.34M
Top Buyers
| 1 | +$171M | |
| 2 | +$116M | |
| 3 | +$113M | |
| 4 |
Goldman Sachs
New York
|
+$85.8M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$63.4M |
Top Sellers
| 1 | -$7.22M | |
| 2 | -$3.12M | |
| 3 | -$1.98M | |
| 4 |
KC
Kepos Capital
New York
|
-$1.26M |
| 5 |
PWPS
Pinnacle Wealth Planning Services
Mansfield,
Ohio
|
-$666K |